Beneficial bacteria occupy specific regions in the gut, contributing to our health via the microbiome. A new study has identified the genes that good bacteria use to colonize these regions, opening ...
Lactobacillus, a beneficial bacterial species (magenta), attaches to specific regions (green) of the fruit fly gastrointestinal tract (white). Baltimore, MD—A team of researchers led by Carnegie ...
DANVILLE, Calif.--(BUSINESS WIRE)--Nexilico, a pioneer in precision microbiome engineering, and Siolta Therapeutics, a leader in the development of live biotherapeutic products (LBPs), have entered ...
Bacterial pathogenesis, evolution, and genomics intersect critically with the ongoing challenge of antimicrobial resistance (AMR), which poses significant ...
According to MarketsandMarkets™, the Human Microbiome Drugs Market is projected to grow from about USD 0.35 billion in 2025 to USD 2.13 billion by 2031, at a CAGR of 35.2%.
Scientists at the Charlie Dunlop School of Biological Sciences at UC Irvine report that they have developed a powerful new tool, called Phollow, that lets scientists watch viral activity in the gut ...
Healthcare Asia Magazine on MSN
Human microbiome drugs market to be valued at $2.13b by 2031
By end users, the hospitals & clinics segment held the largest market share in 2024. The human microbiome drugs market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback